From dog to human: precision medicine for comparative oncology

Presentation Detail

Speaker: Sungwon Lim, PhD, CEO & Co-Founder of ImpriMed, Inc.

Date: January 21, 2020

Description: ‍ImpriMed develops functional precision medicine technologies to help veterinary oncologists find out the most effective treatment options for individual cancer patients by building up a patient-derived database for pet cancer treatment, which can be eventually translated into human cancer care.

Presentations

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023

From dog to human: precision medicine for comparative oncology

Presentation Detail

Presentations

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine

Impact of AI on clinical practice and outcome

Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen

ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care

Reinventing precision medicine: from dogs to humans

Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS

ImpriMed Research Update

Drugs predicted to be effective using artificial intelligence (AI) double the clinical response rate in canines with relapsed B-cell lymphoma

ImpriMed Research Update

Precision medicine for pet cancer care

Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model

ImpriMed: Experiences from the eyes of an oncologist in clinical practice

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

ImpriMed: precision medicine for pet cancer care

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test